Us Bancorp \De\ Sarepta Therapeutics, Inc. Transaction History

Us Bancorp \De\

$77.3 Billion
Q3 2024

A detailed history of Us Bancorp \De\ transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Us Bancorp \De\ holds 6,549 shares of SRPT stock, worth $745,341. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,549

Previous 6,278 4.32%

Holding current value

$745,341

Previous $991,000 17.56%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	BUY	$124.33 - $156.75 $33,693 - $42,479	271 Added 4.32%	6,549 $817,000
Q2 2024 Aug 06, 2024	SELL	$113.33 - $163.85 $242,186 - $350,147	-2,137 Reduced 25.4%	6,278 $991,000
Q1 2024 May 07, 2024	BUY	$93.7 - $141.53 $82,081 - $123,980	876 Added 11.62%	8,415 $1.09 Million
Q4 2023 Feb 09, 2024	BUY	$67.31 - $124.76 $70,204 - $130,124	1,043 Added 16.06%	7,539 $726,000
Q3 2023 Nov 03, 2023	SELL	$102.5 - $123.59 $28,905 - $34,852	-282 Reduced 4.16%	6,496 $787,000
Q2 2023 Aug 09, 2023	SELL	$106.4 - $157.19 $223,333 - $329,941	-2,099 Reduced 23.65%	6,778 $776,000
Q1 2023 May 09, 2023	BUY	$117.53 - $155.99 $61,585 - $81,738	524 Added 6.27%	8,877 $1.22 Million
Q4 2022 Feb 13, 2023	SELL	$100.86 - $132.13 $403,641 - $528,784	-4,002 Reduced 32.39%	8,353 $1.08 Million
Q3 2022 Oct 27, 2022	SELL	$75.71 - $119.24 $3,028 - $4,769	-40 Reduced 0.32%	12,355 $1.36 Million
Q2 2022 Aug 01, 2022	BUY	$62.69 - $88.44 $24,574 - $34,668	392 Added 3.27%	12,395 $929,000
Q1 2022 May 11, 2022	SELL	$63.15 - $90.42 $19,323 - $27,668	-306 Reduced 2.49%	12,003 $937,000
Q4 2021 Feb 11, 2022	BUY	$77.28 - $99.42 $117,388 - $151,018	1,519 Added 14.08%	12,309 $1.11 Million
Q3 2021 Nov 10, 2021	BUY	$65.97 - $92.48 $37,339 - $52,343	566 Added 5.54%	10,790 $998,000
Q2 2021 Aug 05, 2021	BUY	$69.38 - $86.75 $93,663 - $117,112	1,350 Added 15.21%	10,224 $795,000
Q1 2021 Apr 28, 2021	BUY	$72.25 - $168.95 $264,001 - $617,343	3,654 Added 70.0%	8,874 $663,000
Q4 2020 Feb 04, 2021	BUY	$125.56 - $178.74 $349,182 - $497,075	2,781 Added 114.02%	5,220 $890,000
Q3 2020 Nov 10, 2020	BUY	$127.12 - $172.34 $12,712 - $17,234	100 Added 4.28%	2,439 $343,000
Q2 2020 Aug 07, 2020	SELL	$93.0 - $171.7 $1,116 - $2,060	-12 Reduced 0.51%	2,339 $375,000
Q1 2020 May 13, 2020	BUY	$82.38 - $131.64 $5,931 - $9,478	72 Added 3.16%	2,351 $230,000
Q4 2019 Feb 04, 2020	SELL	$76.53 - $135.58 $14,004 - $24,811	-183 Reduced 7.43%	2,279 $295,000
Q3 2019 Nov 08, 2019	BUY	$72.81 - $156.91 $92,395 - $199,118	1,269 Added 106.37%	2,462 $186,000
Q2 2019 Aug 13, 2019	BUY	$112.21 - $151.95 $18,514 - $25,071	165 Added 16.05%	1,193 $181,000
Q1 2019 May 08, 2019	BUY	$106.67 - $151.68 $9,066 - $12,892	85 Added 9.01%	1,028 $122,000
Q4 2018 Feb 13, 2019	BUY	$97.32 - $148.76 $1,265 - $1,933	13 Added 1.4%	943 $103,000
Q3 2018 Nov 01, 2018	SELL	$115.31 - $161.51 $61,114 - $85,600	-530 Reduced 36.3%	930 $151,000
Q2 2018 Aug 08, 2018	SELL	$71.74 - $153.69 $61,337 - $131,404	-855 Reduced 36.93%	1,460 $193,000
Q1 2018 May 08, 2018	SELL	$54.02 - $82.27 $103,124 - $157,053	-1,909 Reduced 45.19%	2,315 $172,000
Q4 2017 Feb 02, 2018	BUY	$47.64 - $56.75 $52,165 - $62,141	1,095 Added 35.0%	4,224 $235,000
Q3 2017 Nov 13, 2017	BUY	$35.73 - $47.15 $111,799 - $147,532	3,129	3,129 $142,000

Others Institutions Holding SRPT

# of Institutions

526

Shares Held

84.4M

Call Options Held

2.06M

Put Options Held

1.52M

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $9.97B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account